Benlysta 200mg/Ml Solution for Injection in Pre-Filled Syringe
Belimumab
200mg/ml
GLAXOSMITHKLINE (IRELAND)LIMITED
| Pack size | 4 Pre-filled Syringes |
|---|---|
| Dispensing mode | POM |
| Source | IRELAND |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 4909.50 AED |
Indications
Benlysta 200mg/Ml Solution for Injection in Pre-Filled Syringe is used for:
Adjunct treatment for auto-antibody-positive active systemic lupus erythematosus.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Belimumab :
Mechanism of Action
Belimumab selectively binds to soluble human B lymphocyte stimulator protein (BLyS) so that BLyS is unable to bind to receptors on B lymphocytes. The binding of BLyS to its receptor is essential for the survival of B lymphocytes. Consequently, belimumab reduces B-cell mediated immunity and the autoimmune response.
Note
Benlysta 200mg/Ml 200mg/ml Solution for Injection in Pre-Filled Syringe manufactured by GLAXOSMITHKLINE (IRELAND)LIMITED. Its generic name is Belimumab. Benlysta 200mg/Ml is availble in United Arab Emirates.
Farmaco UAE drug index information on Benlysta 200mg/Ml Solution for Injection in Pre-Filled Syringe is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.